MetLife, Inc. · MET-PE · FY2026 Q3 · Calendar Q4 2026

MetLife posts record Q3 earnings as investment income and expense control support growth

The quarter supports a view that MetLife’s diversified earnings engines, strong variable investment income and expense discipline can sustain growth. The evidence is not unqualified: variable investment income can be volatile, and management’s discussion surfaced questions around disability costs, mortality trends and spread stability.

How did the market react to MET-PE FY2026 Q3 earnings, and why?

Research this report with FN2. Free to start; review your question before sending.

Reported November 4, 2026After market closeNYSEFinancial Services $47.12B market cap

85quality score

Earnings scorecard

Reported versus consensus

Reported EPS $2.85 Consensus $2.77

EPS surprise +2.9% Reported versus consensus

Reported revenue $19.91B Consensus $19.86B

Revenue surprise +0.3% Reported versus consensus

Market reaction

unavailable

Stock move — Event window

SPY move — Same window

Abnormal move — Stock minus SPY

Volume — Versus trailing sessions

Subsequent drift — Up to 20 sessions

Price and volume data were unavailable at publication time.

Ask FN2 about MET-PE FY2026 Q3

Choose a question to continue your research

How did the market react to MET-PE FY2026 Q3 earnings, and why?What changed in MET-PE's guidance and outlook in FY2026 Q3?Give me the bull and bear case for MET-PE after FY2026 Q3 earnings.

Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.

Transcript intelligence

What changed

Compared with the prior-quarter analysis, the latest call analysis describes a new company record for adjusted earnings per share, with growth supported by variable investment income, disciplined expenses and broad-based segment performance. Management maintained guidance. The analysis also highlights embedded-insurance distribution through Revolut and continued PineBridge integration.

Guidance delta

Maintained; no change to guidance was reported in the supplied analysis.

Key takeaways

The transcript analysis reports adjusted earnings growth of 17% and EPS growth of 22%, reaching a company record.
Variable investment income rose to $720 million, driven by private-equity returns exceeding 4%, while management cited broad-based segment growth.
The direct expense ratio was 11.9%, below the 12.1% annual target despite PineBridge integration.
Management maintained guidance; the analysis cites continued share repurchases and an 11.3% expense-ratio aim by 2029.

Management priorities

Use AI to improve efficiency and revenue while managing costs.
Expand embedded insurance offerings through the Revolut partnership and pursue selective M&A in asset management and group insurance.
Use third-party capital, including Chariot Re, for pension risk-transfer capacity; maintain share repurchases and work toward the stated expense-ratio aim.

Risks

Variable investment income and market-risk-benefit gains can be volatile.
Higher expenses from PineBridge integration and potential pressure from disability and other non-medical health costs.
Normalization of working-age mortality improvements could affect pricing; the supplied analysis also flags uncertainty around RIS core spread and the Q4 outlook for VII.

Analyst concerns

The call analysis records questions about disability versus dental components of the non-medical health loss ratio, stock-based compensation and potential pricing actions amid market softness.
Analysts asked about sustainability of working-age mortality improvements and the drivers of the long-term rise in VNB IRR.
Questions also covered RIS core-spread stability, the Q4 outlook for VII and free-cash-flow conversion versus the stated target.

Editorial confidence: medium
Synthesis relies on the supplied transcript analysis; the market-reaction… · Variable investment income is a meaningful source of the quarter’s growth and…

Follow MET-PE with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match

Show less

Analyst Consensus ?

ConsensusBuy24 ratings

Bullish2083.3%

Neutral416.7%

Bearish00.0%

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

Firm	Rating	Prior rating	Action	Date
JP Morgan	Overweight	Overweight	Maintain	Oct 5, 2023
Jefferies	Buy	Hold	Upgrade	Sep 13, 2023
Morgan Stanley	Overweight	Overweight	Maintain	Aug 17, 2023
Wells Fargo	Overweight	Overweight	Maintain	Aug 14, 2023
Argus Research	Buy	Buy	Maintain	Aug 13, 2023
Citigroup	Buy	Buy	Maintain	Aug 8, 2023
RBC Capital	Outperform	Outperform	Maintain	Aug 3, 2023
Keefe, Bruyette & Woods	Outperform	Outperform	Maintain	Jun 9, 2023
Barclays	Overweight	Overweight	Maintain	Apr 11, 2023
Piper Sandler	Overweight	Overweight	Maintain	Apr 4, 2023
Goldman Sachs	Neutral	Neutral	Maintain	Apr 4, 2023
Credit Suisse	Outperform	Outperform	Maintain	Aug 21, 2022
Evercore ISI Group	Outperform	Outperform	Maintain	Jul 5, 2022
Wolfe Research	Outperform	Peer Perform	Upgrade	Jun 22, 2022
UBS	Buy	Buy	Maintain	Apr 21, 2021
B of A Securities	Buy	Buy	Maintain	Jan 22, 2020
Deutsche Bank	Hold	Hold	Maintain	Apr 11, 2019
B. Riley Securities	Neutral	Neutral	Maintain	Jul 15, 2018
Atlantic Equities	Overweight	Neutral	Upgrade	Mar 25, 2018
FBR Capital	Neutral	Buy	Downgrade	Oct 9, 2017
Macquarie	Outperform	Outperform	Maintain	Feb 3, 2016
Raymond James	Strong Buy	Market Perform	Upgrade	Jan 21, 2016
Sterne Agee	Buy	Buy	Maintain	Oct 12, 2014
Janney Montgomery Scott	Buy	Neutral	Upgrade	Jan 2, 2014

Show 19 more rating actions

Track every rating change on MET-PE the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

MetLife, Inc. is a global financial services corporation that delivers a comprehensive suite of insurance, annuity, employee benefits, and asset management solutions across the world. Its operational structure is organized into five distinct geographical and business segments: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. The company's extensive product catalog includes a variety of insurance offerings such as life, dental, group short-term and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverage. Furthermore, it provides prepaid legal services and administrative services-only (ASO) arrangements tailored for employers.…

Financial Services peers this season

Latest reports in the same sector

Company	Quarter	EPS surprise	Market move	Headline
AFRM Affirm Holdings, Inc.	FY2027 Q1 · Calendar Q4 2026	+23.8%	+1.9%	Affirm pairs strong growth outlook with underwriting and credit watchpoints
MET-PA MetLife, Inc.	FY2026 Q3 · Calendar Q4 2026	+2.9%	—	Record quarter, with investment income and broad segment growth supporting results
GPN Global Payments Inc.	FY2026 Q3 · Calendar Q4 2026	0.0%	-1.2%	Global Payments grows revenue and raises Worldpay synergy target

Latest beats and misses

Who reports next

Beat on EPS

Missed on EPS

Get the MET-PE recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

Earnings call transcript and parsed analysis · 2026-11-05T18:12:10.539601+00:00
FN2 earnings calendar · 2026-11-06T01:23:16.275024+00:00
Polygon adjusted daily market bars

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated November 6, 2026 · As of 2026-11-06. For educational purposes only; not investment advice.